Sandra M. Gurrola - 11 Mar 2022 Form 4/A - Amendment Insider Report for Brooklyn ImmunoTherapeutics, Inc. (ERNA)

Role: Vice President of Finance
Signature: /s/ Sandra Gurrola
Issuer symbol: ERNA
Transactions as of: 11 Mar 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 17 Mar 2022, 21:00:32 UTC
Date Of Original Report: 15 Mar 2022
Previous filing: 22 Jun 2021
Next filing: 23 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ERNA	Stock Option (Right to buy)	Award	$0	+114,500		$0.000000	114,500	11 Mar 2022	Common Stock	114,500	$1.93	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest and become exercisable in 36 substantially equal monthly installments from the grant date.

Remarks:

This Form 4/A amends and restates the original Form 4 filed by the reporting person on March 15, 2022 (the "Original Form 4"). The Original Form 4 reported incorrect vesting terms.